# SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES

> **NCT04482361** · — · COMPLETED · sponsor: **Ministerio de Salud de Ciudad Autónoma de Buenos Aires** · enrollment: 5900 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DIAGNOSTIC_TEST:** Presence of specific anti-SARS-CoV-2 antibodies

## Key facts

- **NCT ID:** NCT04482361
- **Lead sponsor:** Ministerio de Salud de Ciudad Autónoma de Buenos Aires
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-06
- **Primary completion:** 2020-12-22
- **Final completion:** 2020-12-22
- **Target enrollment:** 5900 (ACTUAL)
- **Last updated:** 2021-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04482361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04482361, "SERO-EPIDEMIOLOGY OF SARS-COV2 INFECTION IN THE AUTONOMOUS CITY OF BUENOS AIRES". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT04482361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*